Genetic engineering Study Guide

📖 Core Concepts Genetic Engineering – Direct manipulation of an organism’s DNA (inserting, deleting, or altering genes) using biotechnology. GMO (Genetically Modified Organism) – Any organism that carries introduced DNA. Transgenic vs. Cisgenic – Transgenic: gene comes from a different species. Cisgenic: gene comes from the same species or a sexually compatible one. Synthetic Biology – Extends genetic engineering by building entirely artificial DNA sequences. Gene Therapy – Clinical use of genetic engineering to replace or repair defective human genes. DNA Construct – A plasmid (or other vector) that carries the gene of interest plus regulatory elements (promoter, terminator, selectable marker). Promoter / Terminator – DNA sequences that start and stop transcription, respectively; they act as the “ON” and “OFF” switches for the new gene. Selectable Marker – Usually an antibiotic‑ or herbicide‑resistance gene that lets researchers identify cells that successfully took up the construct. Knock‑out – Deleting a specific gene to study loss‑of‑function. Gain‑of‑function – Adding or over‑expressing a gene to test whether it can produce a new phenotype. Genome Editing Nucleases – Engineered proteins that cut DNA at a chosen site: Zinc‑finger nucleases (ZFNs) TALENs (Transcription‑Activator‑Like Effector Nucleases) CRISPR‑Cas9 (RNA‑guided, easiest design, highest efficiency) --- 📌 Must Remember CRISPR‑Cas9 is the go‑to tool for most edits because it requires only a short guide RNA and works in many organisms. Regulatory Bodies – U.S.: USDA, FDA, EPA (product‑based assessment). EU: EFSA + strict case‑by‑case approval, mandatory labeling >0.9 % GMO content. Labeling – 64 countries require GMO labeling; the EU is the strictest (0 % tolerance for undisclosed GMO DNA). Safety Consensus – Major scientific bodies (WHO, AAAS, NRC) agree that approved GM foods are no riskier than conventional foods. Economic Impact – Meta‑analyses show GM crops generally increase yields and reduce pesticide costs, boosting farmer profitability. Risk Highlights – Gene flow → possible “superweed” formation; resistance evolution in target pests; off‑target mutations (especially with early‑generation nucleases). Legal Milestones – Diamond v. Chakrabarty (1980) allowed patenting of genetically altered organisms. --- 🔄 Key Processes Gene Isolation & Cloning Identify candidate gene → screen, microarray, transcriptomics, or genome data. Cut DNA with restriction enzymes or amplify via PCR. Separate fragment by gel electrophoresis, extract the band. If unavailable, synthesize chemically from known sequence. Ligate into a plasmid vector → transform bacteria → obtain unlimited copies. Construct Preparation Insert promoter → drives transcription. Insert gene of interest (codon‑optimized if needed). Add terminator → stops transcription. Add selectable marker (e.g., antibiotic resistance). DNA Insertion Techniques Bacterial transformation (heat shock or electroporation). Microinjection (directly into animal embryos). Viral vectors (engineered viruses for animal cells). Agrobacterium‑mediated (plant T‑DNA transfer). Biolistics / Gene gun (DNA‑coated particles shot into plant tissue). Selection & Confirmation PCR / Southern blot → confirm DNA integration & copy number. Northern blot / qRT‑PCR → detect RNA transcripts. Western blot / ELISA / immunofluorescence → verify protein expression. Genome Editing (CRISPR example) Design guide RNA complementary to target site. Deliver Cas9‑sgRNA complex into cells. Cas9 creates double‑strand break. Repair pathways: Non‑homologous end joining (NHEJ) → insertions/deletions → knockout. Homology‑directed repair (HDR) with donor template → precise insertion or correction. --- 🔍 Key Comparisons Transgenic vs. Cisgenic Transgenic: foreign‑species DNA → broader trait possibilities, higher regulatory scrutiny. Cisgenic: same‑species DNA → often viewed as “more natural,” may face lighter regulation. CRISPR vs. TALEN vs. ZFN CRISPR: simple RNA guide, high efficiency, low cost. TALEN: protein‑DNA recognition, high specificity, more labor‑intensive. ZFN: earliest nuclease, complex design, lower efficiency. US vs. EU Regulation US: product‑based, “substantial equivalence,” voluntary labeling (except specific states). EU: precautionary, case‑by‑case risk assessment, mandatory labeling >0.9 % GMO content. Random vs. Targeted Insertion Random: integration anywhere in genome (e.g., Agrobacterium, biolistics). Targeted: uses homologous recombination or genome editors → predictable locus, fewer position effects. Knock‑out vs. Overexpression Knock‑out: loss‑of‑function, reveals necessity of a gene. Overexpression: gain‑of‑function, tests sufficiency of a gene product. --- ⚠️ Common Misunderstandings “All GMOs are unsafe.” – Scientific consensus finds approved GM foods as safe as conventional counterparts. “CRISPR automatically produces a heritable change.” – Germline editing requires delivery to reproductive cells; most lab work is somatic. “Labeling means a product is dangerous.” – Labeling is a transparency requirement, not a safety judgment. “Synthetic biology is identical to traditional GM.” – Synthetic biology often creates wholly artificial genetic parts not found in nature. “Gene drives are used in every GMO crop.” – Gene drives are a specialized, self‑propagating technology used mainly in research (e.g., mosquito malaria control). --- 🧠 Mental Models / Intuition DNA construct = “plug‑in module.” Think of a vector as a LEGO brick that carries the gene (the “feature”) plus the wiring (promoter, terminator) and a “test light” (selectable marker). Genome editing = “typo correction in a book.” Cas9 cuts out the wrong word; the cell’s repair machinery inserts the corrected text (HDR) or leaves a small typo (NHEJ). Promoter = “light switch.” No promoter → gene stays off; a strong promoter = bright, constant expression. Selectable marker = “red flag on a map.” Only cells with the flag survive the selection step, making them easy to locate. --- 🚩 Exceptions & Edge Cases CRISPR Off‑Target Effects – Rare but possible; high‑fidelity Cas9 variants reduce risk. Gene Flow Limited to Compatible Species – Transfer only occurs when sexual compatibility or close relatedness exists. EU Labeling Threshold – Even trace amounts (<0.9 %) may trigger labeling in some member states; other countries may have zero‑tolerance policies. Case‑by‑Case Safety Testing – A novel trait (e.g., vitamin‑enhanced rice) must undergo a full dossier review even if the vector is previously approved. Gene Drives – Not used in commercial agriculture yet; subject to separate, stricter biosafety reviews. --- 📍 When to Use Which Choose CRISPR‑Cas9 for most genome edits: quick design, high efficiency, works in bacteria, plants, animals. Use TALENs when ultra‑high specificity is needed (e.g., therapeutic applications with low tolerance for off‑targets). Select Agrobacterium for stable transformation of dicot plants (most vegetables, fruits). Pick Biolistics for monocots or recalcitrant species where Agrobacterium is ineffective. Apply Antibiotic Marker in bacterial work; herbicide‑resistance marker for plant field trials where selection can be done in soil. Knock‑out when you need to test loss of gene function; overexpression when testing sufficiency or producing a protein product. Regulatory pathway: If the product will be sold in the EU → prepare a full pre‑market dossier and labeling plan; for the U.S. → focus on substantial equivalence and FDA safety data. --- 👀 Patterns to Recognize Expression cassette = Promoter → Gene → Terminator (always appears together in constructs). Selection step = Presence of antibiotic/herbicide resistance gene AND growth on selective medium. Regulatory language – “substantial equivalence” signals a U.S.‑style assessment; “case‑by‑case” or “traceability” points to EU or Canadian frameworks. Resistance management – Repeated use of the same Bt toxin → look for reports of pest resistance; rotating traits is a common mitigation pattern. Safety testing checklist – Nutrient composition, toxicology, allergenicity, horizontal gene transfer → appears in most GMO dossiers. --- 🗂️ Exam Traps Distractor: “All transgenic plants are automatically classified as “superweeds.” Why tempting: Gene flow is a real concern. Why wrong: Only compatible wild relatives can acquire the trait; many transgenes are designed for sterility or confined expression. Distractor: “CRISPR can edit any genome without off‑target risk.” Why tempting: CRISPR’s reputation for precision. Why wrong: Off‑target cleavage can occur; high‑fidelity variants and thorough validation are needed. Distractor: “EU labeling applies to any product containing trace GMO DNA, even if the DNA is non‑functional.” Why tempting: EU’s strict labeling stance. Why wrong: EU requires labeling when GMO material is present above 0.9 % of the product; trace, non‑detectable levels may be exempt. Distractor: “Synthetic biology always involves inserting genes from other species.” Why tempting: Association with “artificial” DNA. Why wrong: Synthetic biology can use wholly synthetic sequences with no natural counterpart. Distractor: “Gene therapy and agricultural GMO regulation are identical.” Why tempting: Both involve engineered DNA. Why wrong: Gene therapy is regulated as a medical product (FDA, EMA), whereas agricultural GMOs follow food/plant safety frameworks. ---